Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute Revenue
Non-profit Organizations • 
Sydney, New South Wales, Australia • 21-50 Employees
Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute revenue & valuation
| Annual revenue | $18,500,000 |
| Revenue per employee | $487,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Non-profit Organizations industry and current estimated revenues | $59,200,000 |
| Total funding | No funding |
Key Contacts at Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute
Stephen Ackland
Director
Joanne Cory
Chief Executive Officer
Company overview
| Headquarters | Sydney, New South Wales, Australia |
| Phone number | +61272082701 |
| Website | |
| NAICS | 813 |
| SIC | 839 |
| Keywords | Cancer, Clinical Trials, Liver, Pancreas, Raise Awareness, Bowel, Gastro-Intestinal Cancer Research, Save Lives, Stomach, Agitg, Gall Bladder, Oesophagus, Cholangiocarcinoma |
| Founded | 1991 |
| Employees | 21-50 |
Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute Email Formats
Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute uses 2 email formats. The most common is {first name} (e.g., john@gicancer.org.au), used 68.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@gicancer.org.au | 68.8% |
{first initial} | j@gicancer.org.au | 31.2% |
About Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute
Gastro-Intestinal (GI) cancer is the most common form of cancer in Australia. It affects more than 37,780 Australians each year and claims 50 lives every day. GI cancer includes cancers of the digestive system – oesophagus, stomach, liver, gallbladder and biliary tract, pancreas, large and small bowel, rectum and anus. Despite its prevalence, survival rates remain low: the chance of surviving five years after diagnosis is just 48.4%. We’re working to change that. By uniting a diverse network of brilliant clinicians, researchers, and community advocates, we deliver clinical trials that lead to better treatments, improved quality of life, and longer survival. Since 1991, we’ve conducted 90 research studies, giving more than 9,930 people access to promising new treatments, faster. Clinical trials are how progress happens. They test whether new treatments work better than the current standard of care, and they’re essential to ensuring new therapies are safe, effective, and ready to be used more widely. For patients, clinical trials can offer immediate access to the latest treatments and often improve both outcomes and quality of life. Running trials here in Australia means people can benefit from these advances up to five years earlier than if the trials were held overseas.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute has 13 employees across 8 departments.
Departments
Number of employees
Funding Data
Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute has never raised funding before.
Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute Tech Stack
Discover the technologies and tools that power Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute's digital infrastructure, from frameworks to analytics platforms.
Hosting
WordPress plugins
Miscellaneous
Maps
CDN
SEO
JavaScript libraries
WordPress plugins
Programming languages
WordPress plugins
Blogs
Finland
United States
France
Spain
Frequently asked questions
4.8
40,000 users
